Kronik Tromboembolik Pulmoner Hipertansiyonda Pulmoner Tromboendarterektomi

Kim NH, Delcroix M, Jais X, et al. Chronic Thromboembolic Pulmonary Hypertension. Eur Respir J. 2019 Jan 24;53(1):1801915. doi: 10.1183/13993003.01915-2018.

Pengo V, Lensing AW, Prins MH, et al. Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257-64.

Sanchez O, Helley D, Couchon S, et al. Perfusion defects after pulmonary embolism: risk factors and clinical significance. J Thromb Haemost. 2010 Jun;8(6):1248-55. doi: 10.1111/j.1538-7836.2010.03844.x.

Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2005;93(3):512-6.

Nystrom G. Experiences with the Trendelenburg Operation for Pulmonary Embolsim. Ann Surg. 1930;92(4):498-532.

Daily PO, Dembitsky WP, Daily RP. Dissectors for pulmonary thromboendarterectomy. Ann Thorac Surg. 1991;51(5):842-3.

Daily PO, Dembitsky WP, Iversen S, et al. Risk factors for pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg. 1990 ;99(4):670-8.

Daily PO, Dembitsky WP, Jamieson SW. The evolution and the current state of the art of pulmonary thromboendarterectomy. Semin Thorac Cardiovasc Surg. 1999;11(2):152-63.

Daily PO, Auger WR. Historical perspective: surgery for chronic thromboembolic disease. Semin Thorac Cardiovasc Surg. 1999;11(2):143-51.

Sacks RS, Remillard CV, Agange N, et al. Molecular biology of chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006 ;18(3):265-76.

Sacks RS, Firth AL, Remillard CV, et al.Thrombin-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2008 ;295(6):L1048-55.

Dorfmüller P, Günther S, Ghigna MR, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014 Nov;44(5):1275-88. doi: 10.1183/09031936.00169113. Epub 2014 Aug 19.

Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: an updated review. Curr Opin Cardiol. 2008;23(6):555-9.

Kerr KM, Elliott CG, Chin K, et al. Results from the United States Chronic Thromboembolic Pulmonary Hypertension Registry: enrollment charecteristicsand 1 year follow-up. Chest. 2021 Nov;160(5):1822-1831. doi: 10.1016/j.chest.2021.05.052. Epub 2021 Jun 4.

Le Gal G, Delahousse B, Lacut K, et al. Groupe d'Etudes sur la Thrombose des Hôpitaux Universitaires du Grand Ouest. Fibrinogen Aalpha-Thr312Ala and factor XIII-AVal34Leu polymorphisms in idiopathic venous thromboembolism. Thromb Res. 2007;121(3):333-8.

Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen Aalpha Thr312 Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2008;31(4):736-41.

Kapitan KS, Buchbinder M, Wagner PD, et al. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis. 1989;139(5):1149-54.

Lang I. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol. 2010 May;149(4):478-83. doi: 10.1111/j.1365-2141.2010.08142.

Elhage Hassan M, Vinales J, Perkins S, et al. Pathogenesis ,Diagnosis and Management of Chronic Thromboembolic Pulmonary Hypertension. Interv Cardiol Clin. 2023 Jul;12(3S):e37-e49. doi: 10.1016/j.iccl.2024.04.003.

Teerapuncharoen K, Bag R. Chronic Thromboembolic Pulmonary Hypertension. Lung 2022:200; 283-299.

Ryan KL, Fedullo PF, Davis GB, et al. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest. 1988;93(6):1180-5.

Auger WR, Fedullo PF, Moser KM, et al. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology. 1992 ;182(2):393-8.

Dogan H, de Roos A, Geleijins J, et al. The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol. 2015 Jul-Aug;21(4):307-16. doi: 10.5152/dir.2015.14403.

Gopalan D, Riley JYJ, Leong K, Alsanjari S, et al. Computed Tomography Pulmonary Angiography Prediction of Adverse Long-Term Outcomes in Chronic Thromboembolic Pulmonary Hypertension: Correlation with Hemodynamic Measurements Pre- and Post-Pulmonary Endarterectomy. Tomography. 2023 Sep 26;9(5):1787-1798. doi: 10.3390/tomography9050142.

Gopalan D, Riley JYJ, Leong K, et al. Pulmonary Vein Sign on Computed Tomography Pulmonary Angiography in Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension With Hemodynamic Correlation. J Thorac Imaging. 2023 May 1;38(3):159-164. doi: 10.1097/RTI.0000000000000706. Epub 2023 Mar 15.

Gopalan D, Delcroix M, Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017 Mar 15;26(143):160108. doi: 10.1183/16000617.0108-2016. Print 2017 Jan.

Guth S, Wiedenroth CB, Rieth A, et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J. 2018 Sep 17;52(3):1800458. doi: 10.1183/13993003.00458-2018. Print 2018 Sep.

Yang J, Madani MM, Mahmud E, et al. Evaluation and management of chronic thromboembolic pulmonary hypertension. Chest. 2023 Aug;164(2):490-502. doi: 10.1016/j.chest.2023.03.029. Epub 2023 Mar 28.

Ulrich S, Fischler M, Speich R, et al. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest. 2006;130(3):841-6.

McNeil K, Dunning J. Chronic thromboembolic pulmonary hypertension (CTEPH). Heart. 2007 ;93(9):1152-8.

Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23(4):637-48.

Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18(3):243-9.

Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160(2):523-8.

Kunihara T, Möller M, Langer F, et al. Angiographic predictors of hemodynamic improvement after pulmonary endarterectomy. Ann Thorac Surg. 2010;90(3):957-64.

Poli D, Miniati M. The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism. Curr Opin Pulm Med. 2011 Jul 7 Epub.

Bresser P, Pepke-Zaba J, Jaïs X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc. 2006;3(7):594-600.

Ghofrani HA, Hoeper MM, Halank M, et al. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. Eur Respir J. 2010;36(4):792-9.

Becattini C, Manina G, Busti C, et al. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res. 2010;126(1):e51-6.

Jaïs X, D'Armini AM, Jansa P, et al. Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErableForms of chronIc Thromboembolic pulmonary hypertension), a randomized,placebo-controlled trial. J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34.

Kenny M, Clarke MM, Pogue KT. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension. J Pharm Pract. 2022 Jun;35(3):437-444. doi: 10.1177/0897190020961291. Epub 2020 Oct 21.

Krug S, Hammerschmidt S, Pankau H, et al. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration. 2008;76(2):154-9.

Kramm T, Eberle B, Guth S, et al. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005 ;28(6):882-8.

Toshner MR, Gopalan D, Suntharalingam J, et al. Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2010;29(6):610-5.

Suntharalingam J, Treacy CM, Doughty NJ, et al. Long-term use of sildenafil ininoperable chronic thromboembolic pulmonary hypertension. Chest. 2008;134(2):229-36.

Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002;124(6):1203-11.

Suntharalingam J, Hughes RJ, Goldsmith K, et al. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH). Vascul Pharmacol. 2007;46(6):449-55.

Olman MA, Auger WR, Fedullo PF, et al. Pulmonary vascular steal in chronic thromboembolic pulmonary hypertension. Chest. 1990;98(6):1430-4.

Moser KM, Metersky ML, Auger WR, et al. Resolution of vascular steal after pulmonary thromboendarterectomy. Chest. 1993;104(5):1441-4.

Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg. 2006;18(3):250-6.

Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis. 1986;134(6):1241-5.

Kramm T, Eberle B, Krummenauer F, et al. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg. 2003;76(3):711-8.

Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005;28(6):882-8.

Thistlethwaite PA, Madani MM, Kemp AD, et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82(6):2139-45.

Dittrich HC, Chow LC, Nicod PH. Early improvement in left ventricular diastolic function after relief of chronic right ventricular pressure overload. Circulation. 1989 ;80(4):823-30.

Casaclang-Verzosa G, McCully RB, Oh JK, et al. Effects of pulmonary thromboendarterectomy on right-sided echocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension. Mayo Clin Proc. 2006;81(6):777-82.

Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685-92.

Sandoval J, Gaspar J, Pulido T, et al.Graded balloon dilation atrial septostomy in severe primarypulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32(2):297-304.

Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349(12):1133-8.

Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3(5):848-53.

Humbert M, Simonneau G, Pittrow D, et al. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2022 Jun;41(6):716-721. doi: 10.1016/j.healun.2022.02.002.

Yang JZ, Poch DS, Ang L, et al. Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here? Pulm Circ. 2023 Nov 20;13(4):e12312. doi: 10.1002/pul2.12312.

Hirakawa K, Yamamoto E, Takashio S, et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther. 2022;37(1):60-65. doi: 10.1007/s12928-021-00775-6.

Lloji A, Hooda U, Sreenivasan J, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Am J Cardiovasc Dis. 2021 Jun 15;11(3):330-347.

Corsico AG, D'Armini AM, Cerveri I, et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med. 2008;178(4):419-24.

Condliffe R, Kiely DG, Gibbs JS, et al.Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177(10):1122-7.

Thistlethwaite PA, Kemp A, Du L, et al. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2006;131(2):307-13.